5mv1 › Citations

The structure differences of Japanese encephalitis virus SA14 and SA14-14-2 E proteins elucidate the virulence attenuation mechanism.

Figure 1
Liu X, Zhao X, Na R, Li L, Warkentin E, Witt J, Lu X, Yu Y, Wei Y, Peng G, Li Y, Wang J
OpenAccess logo Protein Cell 10 149-153 (2019)
Cited: 16 times
EuropePMC logo PMID: 29752689

Reviews - 5mv1 mentioned but not cited (4)

  1. Glycosylation of viral proteins: Implication in virus-host interaction and virulence. Feng T, Zhang J, Chen Z, Pan W, Chen Z, Yan Y, Dai J. Virulence 13 670-683 (2022)
  2. The key amino acids of E protein involved in early flavivirus infection: viral entry. Hu T, Wu Z, Wu S, Chen S, Cheng A. Virol J 18 136 (2021)
  3. Glycosaminoglycan binding by arboviruses: a cautionary tale. Alcorn MDH, Klimstra WB. J Gen Virol 103 (2022)
  4. Molecular Mechanism and Role of Japanese Encephalitis Virus Infection in Central Nervous System-Mediated Diseases. Yadav P, Chakraborty P, Jha NK, Dewanjee S, Jha AK, Panda SP, Mishra PC, Dey A, Jha SK. Viruses 14 2686 (2022)

Articles - 5mv1 mentioned but not cited (3)

  1. Crystal structure of Usutu virus envelope protein in the pre-fusion state. Chen Z, Ye F, Lin S, Yang F, Cheng Y, Cao Y, Chen Z, Lu G. Virol J 15 183 (2018)
  2. Genomic Characteristics and E Protein Bioinformatics Analysis of JEV Isolates from South China from 2011 to 2018. Sun Y, Ding H, Zhao F, Yan Q, Li Y, Niu X, Zeng W, Wu K, Ling B, Fan S, Zhao M, Yi L, Chen J. Vaccines (Basel) 10 1303 (2022)
  3. Analysis, Modeling, and Target-Specific Predictions of Linear Peptides Inhibiting Virus Entry. Vishnepolsky B, Grigolava M, Gabrielian A, Rosenthal A, Hurt D, Tartakovsky M, Pirtskhalava M. ACS Omega 8 46218-46226 (2023)


Reviews citing this publication (2)

  1. Early Events in Japanese Encephalitis Virus Infection: Viral Entry. Yun SI, Lee YM. Pathogens 7 E68 (2018)
  2. Antiviral drug research for Japanese encephalitis: an updated review. Joe S, Salam AAA, Neogi U, N NB, Mudgal PP. Pharmacol Rep 74 273-296 (2022)

Articles citing this publication (7)

  1. Crystal Structure of the Japanese Encephalitis Virus Capsid Protein. Poonsiri T, Wright GSA, Solomon T, Antonyuk SV. Viruses 11 E623 (2019)
  2. Partial cross-protection between Japanese encephalitis virus genotype I and III in mice. Wei J, Wang X, Zhang J, Guo S, Pang L, Shi K, Liu K, Shao D, Qiu Y, Liu L, Widén F, Li B, Ma Z. PLoS Negl Trop Dis 13 e0007601 (2019)
  3. Japanese encephalitis virus live attenuated vaccine strains display altered immunogenicity, virulence and genetic diversity. Davis EH, Beck AS, Li L, White MM, Greenberg MB, Thompson JK, Widen SG, Barrett ADT, Bourne N. NPJ Vaccines 6 112 (2021)
  4. Reduction patterns of Japanese encephalitis incidence following vaccine introduction into long-term expanded program on immunization in Yunnan Province, China. Hu XT, Li QF, Ma C, Zhao ZX, He LF, Tang TT, Yu W, Owiti P. Infect Dis Poverty 8 102 (2019)
  5. Phenotypic and Genotypic Comparison of a Live-Attenuated Genotype I Japanese Encephalitis Virus SD12-F120 Strain with Its Virulent Parental SD12 Strain. Anwar MN, Wang X, Hameed M, Wahaab A, Li C, Sharma M, Pang L, Malik MI, Liu K, Li B, Qiu Y, Wei J, Ma Z. Viruses 12 E552 (2020)
  6. Isolation and Genetic Characterization of Japanese Encephalitis Virus Two Decades after Its Elimination in Singapore. Lim MJ, Loh ZY, Yeo HL, Yenamandra SP, Kong M, Pang HY, Lee MH, Humaidi M, Chua C, Griffiths J, Ng LC, Hapuarachchi HC, Mailepessov D. Viruses 14 2662 (2022)
  7. Attenuated Chimeric GI/GIII Vaccine Candidate against Japanese Encephalitis Virus. Lee E, Kim M, Kim YB. Vaccines (Basel) 11 1827 (2023)


Quick links